Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 21 | 2022 | 281 | 7.970 |
Why?
|
Zebrafish | 28 | 2023 | 300 | 6.050 |
Why?
|
Melanocytes | 12 | 2023 | 65 | 4.320 |
Why?
|
Bone Morphogenetic Proteins | 3 | 2021 | 54 | 2.210 |
Why?
|
Proto-Oncogene Proteins B-raf | 7 | 2022 | 50 | 1.920 |
Why?
|
Skin Neoplasms | 4 | 2022 | 349 | 1.500 |
Why?
|
ras Proteins | 6 | 2017 | 70 | 1.470 |
Why?
|
Growth Differentiation Factor 6 | 2 | 2019 | 3 | 1.460 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2021 | 459 | 1.310 |
Why?
|
Zebrafish Proteins | 6 | 2020 | 144 | 1.280 |
Why?
|
Neural Crest | 3 | 2021 | 27 | 1.210 |
Why?
|
Microphthalmia-Associated Transcription Factor | 4 | 2019 | 9 | 1.130 |
Why?
|
Animals | 38 | 2023 | 17734 | 1.110 |
Why?
|
Animals, Genetically Modified | 13 | 2021 | 286 | 1.110 |
Why?
|
Disease Models, Animal | 8 | 2022 | 1787 | 0.930 |
Why?
|
Signal Transduction | 8 | 2023 | 2689 | 0.900 |
Why?
|
Carcinogenesis | 2 | 2021 | 112 | 0.890 |
Why?
|
Mutation | 10 | 2022 | 2190 | 0.880 |
Why?
|
Cell Differentiation | 5 | 2023 | 1233 | 0.860 |
Why?
|
Vitiligo | 1 | 2022 | 95 | 0.760 |
Why?
|
Oncogenes | 3 | 2016 | 60 | 0.760 |
Why?
|
Neoplasms | 4 | 2019 | 1058 | 0.720 |
Why?
|
Gene Expression Regulation, Developmental | 5 | 2021 | 587 | 0.690 |
Why?
|
Melanosomes | 1 | 2017 | 1 | 0.670 |
Why?
|
Receptor, Metabotropic Glutamate 5 | 1 | 2017 | 2 | 0.670 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2017 | 33 | 0.650 |
Why?
|
Caenorhabditis elegans Proteins | 5 | 2006 | 367 | 0.650 |
Why?
|
Cyclic AMP | 1 | 2017 | 130 | 0.640 |
Why?
|
Regeneration | 2 | 2015 | 87 | 0.640 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 190 | 0.580 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 169 | 0.580 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 256 | 0.580 |
Why?
|
Caenorhabditis elegans | 5 | 2006 | 563 | 0.570 |
Why?
|
Genetic Variation | 1 | 2017 | 337 | 0.560 |
Why?
|
Nevus | 4 | 2022 | 16 | 0.560 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 41 | 0.460 |
Why?
|
Pigmentation | 4 | 2019 | 22 | 0.450 |
Why?
|
Vulva | 4 | 2006 | 15 | 0.430 |
Why?
|
Genes, Helminth | 3 | 2006 | 51 | 0.430 |
Why?
|
Gene Amplification | 1 | 2011 | 22 | 0.420 |
Why?
|
Protein Methyltransferases | 1 | 2011 | 13 | 0.420 |
Why?
|
Cell Line, Tumor | 3 | 2022 | 1249 | 0.420 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2011 | 32 | 0.420 |
Why?
|
DNA Copy Number Variations | 1 | 2011 | 60 | 0.410 |
Why?
|
Hematopoiesis | 3 | 2017 | 113 | 0.400 |
Why?
|
Skin | 2 | 2023 | 317 | 0.370 |
Why?
|
Humans | 18 | 2022 | 49664 | 0.350 |
Why?
|
Repressor Proteins | 4 | 2006 | 309 | 0.350 |
Why?
|
Genes, APC | 1 | 2007 | 10 | 0.340 |
Why?
|
Ligands | 2 | 2019 | 380 | 0.320 |
Why?
|
Models, Animal | 3 | 2021 | 197 | 0.300 |
Why?
|
Stem Cells | 3 | 2023 | 239 | 0.300 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 194 | 0.290 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2014 | 186 | 0.290 |
Why?
|
HEK293 Cells | 2 | 2017 | 527 | 0.280 |
Why?
|
Embryo, Nonmammalian | 4 | 2021 | 162 | 0.260 |
Why?
|
Acetyltransferases | 1 | 2004 | 22 | 0.260 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 280 | 0.260 |
Why?
|
Hematopoietic Stem Cells | 3 | 2017 | 243 | 0.250 |
Why?
|
Hair Follicle | 1 | 2023 | 23 | 0.240 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2004 | 147 | 0.230 |
Why?
|
Tetraploidy | 1 | 2022 | 2 | 0.230 |
Why?
|
Diacylglycerol O-Acyltransferase | 1 | 2022 | 11 | 0.230 |
Why?
|
Cytokinesis | 1 | 2022 | 37 | 0.230 |
Why?
|
Adenosine Triphosphatases | 1 | 2004 | 222 | 0.230 |
Why?
|
Mammals | 1 | 2023 | 155 | 0.220 |
Why?
|
Trans-Activators | 1 | 2004 | 281 | 0.220 |
Why?
|
Mice | 5 | 2022 | 9096 | 0.220 |
Why?
|
Cell Count | 1 | 2021 | 121 | 0.220 |
Why?
|
Helminth Proteins | 1 | 2001 | 37 | 0.210 |
Why?
|
Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 11 | 0.200 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 110 | 0.200 |
Why?
|
Base Sequence | 2 | 2017 | 1253 | 0.200 |
Why?
|
Cell Movement | 1 | 2021 | 386 | 0.190 |
Why?
|
Biopsy | 1 | 2021 | 326 | 0.190 |
Why?
|
Cell Cycle Proteins | 1 | 2001 | 358 | 0.170 |
Why?
|
Research Design | 1 | 2022 | 528 | 0.170 |
Why?
|
Cloning, Molecular | 2 | 2014 | 349 | 0.170 |
Why?
|
Splenomegaly | 1 | 2017 | 22 | 0.170 |
Why?
|
Green Fluorescent Proteins | 2 | 2017 | 319 | 0.170 |
Why?
|
Thymocytes | 1 | 2017 | 18 | 0.170 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2017 | 5 | 0.170 |
Why?
|
Cell Lineage | 4 | 2017 | 237 | 0.160 |
Why?
|
Mice, Nude | 1 | 2017 | 215 | 0.160 |
Why?
|
Genes, p53 | 2 | 2015 | 48 | 0.160 |
Why?
|
In Situ Hybridization | 1 | 2017 | 198 | 0.160 |
Why?
|
Genes, Reporter | 1 | 2017 | 216 | 0.160 |
Why?
|
Transcription Factors | 2 | 2004 | 1356 | 0.150 |
Why?
|
Lymphocytes | 1 | 2017 | 170 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 596 | 0.150 |
Why?
|
Phylogeny | 1 | 2017 | 295 | 0.150 |
Why?
|
Survival Analysis | 1 | 2017 | 473 | 0.150 |
Why?
|
Blotting, Western | 1 | 2017 | 534 | 0.150 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 55 | 0.150 |
Why?
|
Molecular Sequence Data | 3 | 2006 | 1886 | 0.150 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 816 | 0.140 |
Why?
|
Disease Progression | 2 | 2020 | 718 | 0.140 |
Why?
|
Kidney | 1 | 2017 | 344 | 0.140 |
Why?
|
Adult Stem Cells | 1 | 2015 | 28 | 0.140 |
Why?
|
Female | 6 | 2021 | 26336 | 0.140 |
Why?
|
Wnt Signaling Pathway | 1 | 2015 | 59 | 0.140 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 245 | 0.130 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 189 | 0.130 |
Why?
|
Chronic Disease | 1 | 2017 | 670 | 0.130 |
Why?
|
Wound Healing | 1 | 2015 | 146 | 0.130 |
Why?
|
RNA | 1 | 2017 | 360 | 0.130 |
Why?
|
Open Reading Frames | 1 | 2014 | 79 | 0.130 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 87 | 0.120 |
Why?
|
Transcription, Genetic | 2 | 2016 | 821 | 0.120 |
Why?
|
Mitosis | 1 | 2015 | 196 | 0.120 |
Why?
|
Cell Proliferation | 2 | 2015 | 885 | 0.120 |
Why?
|
Cytosine | 1 | 2012 | 26 | 0.120 |
Why?
|
Chromatin | 1 | 2017 | 541 | 0.120 |
Why?
|
Phenotype | 3 | 2008 | 996 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 684 | 0.110 |
Why?
|
Staining and Labeling | 1 | 2012 | 123 | 0.110 |
Why?
|
Aged, 80 and over | 1 | 2021 | 4220 | 0.110 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 1498 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 19 | 0.110 |
Why?
|
Genes, Homeobox | 1 | 2011 | 20 | 0.110 |
Why?
|
Inflammation | 1 | 2017 | 981 | 0.100 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 621 | 0.100 |
Why?
|
Age of Onset | 1 | 2011 | 161 | 0.100 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 1500 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 143 | 0.100 |
Why?
|
Nuclear Proteins | 3 | 2008 | 750 | 0.100 |
Why?
|
Blood Physiological Phenomena | 1 | 2009 | 1 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2012 | 320 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 1 | 2009 | 18 | 0.090 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 587 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2016 | 1042 | 0.090 |
Why?
|
Genes, Tumor Suppressor | 1 | 2009 | 70 | 0.090 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2008 | 7 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2014 | 668 | 0.090 |
Why?
|
Microinjections | 1 | 2008 | 60 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2008 | 26 | 0.090 |
Why?
|
Allelic Imbalance | 1 | 2007 | 7 | 0.080 |
Why?
|
Polyploidy | 1 | 2007 | 12 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2008 | 89 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 63 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 275 | 0.080 |
Why?
|
Chromosome Aberrations | 1 | 2007 | 60 | 0.080 |
Why?
|
Histone Deacetylases | 2 | 2006 | 58 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2007 | 68 | 0.080 |
Why?
|
DNA, Helminth | 1 | 2006 | 8 | 0.080 |
Why?
|
Crosses, Genetic | 1 | 2006 | 98 | 0.070 |
Why?
|
Aged | 1 | 2021 | 10870 | 0.070 |
Why?
|
Genetic Linkage | 1 | 2006 | 97 | 0.070 |
Why?
|
Male | 2 | 2021 | 23132 | 0.070 |
Why?
|
Heterozygote | 1 | 2006 | 158 | 0.070 |
Why?
|
Gene Transfer Techniques | 1 | 2008 | 263 | 0.070 |
Why?
|
Middle Aged | 1 | 2021 | 13450 | 0.070 |
Why?
|
Adult | 1 | 2021 | 13331 | 0.070 |
Why?
|
Alleles | 1 | 2006 | 410 | 0.070 |
Why?
|
Lysine Acetyltransferase 5 | 1 | 2004 | 10 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2004 | 99 | 0.060 |
Why?
|
DNA, Complementary | 1 | 2004 | 159 | 0.060 |
Why?
|
Histone Acetyltransferases | 1 | 2004 | 50 | 0.060 |
Why?
|
Liver | 1 | 2008 | 709 | 0.060 |
Why?
|
Macromolecular Substances | 1 | 2004 | 152 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 337 | 0.060 |
Why?
|
Oncogene Proteins | 1 | 2022 | 41 | 0.060 |
Why?
|
Down-Regulation | 1 | 2003 | 280 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2004 | 366 | 0.050 |
Why?
|
E2F Transcription Factors | 1 | 2001 | 16 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 186 | 0.050 |
Why?
|
Triglycerides | 1 | 2022 | 239 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2022 | 249 | 0.050 |
Why?
|
Immunity | 1 | 2021 | 95 | 0.050 |
Why?
|
Cell Division | 1 | 2001 | 398 | 0.050 |
Why?
|
Gene Deletion | 1 | 2001 | 297 | 0.050 |
Why?
|
Transgenes | 2 | 2011 | 148 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2012 | 281 | 0.040 |
Why?
|
Immunotherapy | 1 | 2021 | 219 | 0.040 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 48 | 0.040 |
Why?
|
Survival Rate | 1 | 2020 | 656 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2001 | 558 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 142 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 1251 | 0.040 |
Why?
|
Protein Binding | 1 | 2001 | 1475 | 0.040 |
Why?
|
Neurons | 1 | 2001 | 757 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2020 | 2017 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2016 | 172 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2016 | 211 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2016 | 811 | 0.030 |
Why?
|
Dioxygenases | 1 | 2012 | 12 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2012 | 19 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 13 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2016 | 861 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 296 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 25 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2009 | 18 | 0.020 |
Why?
|
Rhabdomyosarcoma | 1 | 2009 | 14 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2009 | 143 | 0.020 |
Why?
|
Liver Regeneration | 1 | 2008 | 17 | 0.020 |
Why?
|
Genes, bcl-2 | 1 | 2008 | 9 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2009 | 151 | 0.020 |
Why?
|
Cleavage Stage, Ovum | 1 | 2008 | 6 | 0.020 |
Why?
|
Genes, myc | 1 | 2008 | 20 | 0.020 |
Why?
|
Albinism | 1 | 2008 | 1 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2009 | 148 | 0.020 |
Why?
|
Hepatectomy | 1 | 2008 | 46 | 0.020 |
Why?
|
Endoderm | 1 | 2008 | 41 | 0.020 |
Why?
|
Body Patterning | 1 | 2008 | 76 | 0.020 |
Why?
|
beta Catenin | 1 | 2008 | 84 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 49 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 146 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2008 | 114 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2008 | 102 | 0.020 |
Why?
|
Light | 1 | 2008 | 192 | 0.020 |
Why?
|
Hepatocytes | 1 | 2008 | 169 | 0.020 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2006 | 17 | 0.020 |
Why?
|
Molecular Weight | 1 | 2006 | 178 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2008 | 637 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2006 | 141 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 1312 | 0.020 |
Why?
|
Apoptosis | 1 | 2008 | 978 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 1061 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 2857 | 0.010 |
Why?
|
Time Factors | 1 | 2008 | 3127 | 0.010 |
Why?
|